These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Th17-Inducing Conditions Lead to in vitro Activation of Both Th17 and Th1 Responses in Behcet's Disease. Deniz R, Tulunay-Virlan A, Ture Ozdemir F, Unal AU, Ozen G, Alibaz-Oner F, Aydin-Tatli I, Mumcu G, Ergun T, Direskeneli H. Immunol Invest; 2017 Jul; 46(5):518-525. PubMed ID: 28414558 [Abstract] [Full Text] [Related]
4. Up-regulation of Th17 and related cytokines in Behçet's disease corresponding to disease activity. Na SY, Park MJ, Park S, Lee ES. Clin Exp Rheumatol; 2013 Jul; 31(3 Suppl 77):32-40. PubMed ID: 24064012 [Abstract] [Full Text] [Related]
5. Serum IL-33 levels and skin mRNA expression in Behçet's disease. Hamzaoui K, Kaabachi W, Fazaa B, Zakraoui L, Mili-Boussen I, Haj-Sassi F. Clin Exp Rheumatol; 2013 Jul; 31(3 Suppl 77):6-14. PubMed ID: 23464866 [Abstract] [Full Text] [Related]
6. Excessive CD4+ T cells co-expressing interleukin-17 and interferon-γ in patients with Behçet's disease. Shimizu J, Takai K, Fujiwara N, Arimitsu N, Ueda Y, Wakisaka S, Yoshikawa H, Kaneko F, Suzuki T, Suzuki N. Clin Exp Immunol; 2012 Apr; 168(1):68-74. PubMed ID: 22385240 [Abstract] [Full Text] [Related]
7. Immune responses to interphotoreceptor retinoid-binding protein and S-antigen in Behcet's patients with uveitis. Takeuchi M, Usui Y, Okunuki Y, Zhang L, Ma J, Yamakawa N, Hattori T, Kezuka T, Sakai J, Goto H. Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3067-75. PubMed ID: 20089879 [Abstract] [Full Text] [Related]
8. Upregulated IL-23 and IL-17 in Behçet patients with active uveitis. Chi W, Zhu X, Yang P, Liu X, Lin X, Zhou H, Huang X, Kijlstra A. Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):3058-64. PubMed ID: 18579762 [Abstract] [Full Text] [Related]
9. Critical regulation of Th17 cell differentiation by serum amyloid-A signalling in Behcet's disease. Lucherini OM, Lopalco G, Cantarini L, Emmi G, Lopalco A, Venerito V, Vitale A, Iannone F. Immunol Lett; 2018 Sep; 201():38-44. PubMed ID: 30385329 [Abstract] [Full Text] [Related]
14. IL-17, IL-10, IL-6, and IFN-γ in Egyptian Behçet's disease: correlation with clinical manifestations. Talaat RM, Sibaii H, Bassyouni IH, El-Wakkad A. Eur Cytokine Netw; 2019 Mar 01; 30(1):15-22. PubMed ID: 31122907 [Abstract] [Full Text] [Related]
15. Production of interleukin-17 in Behcet's disease is inhibited by cyclosporin A. Chi W, Yang P, Zhu X, Wang Y, Chen L, Huang X, Liu X. Mol Vis; 2010 May 19; 16():880-6. PubMed ID: 20508866 [Abstract] [Full Text] [Related]
17. IFN-alpha blocks IL-17 production by peripheral blood mononuclear cells in Behcet's disease. Liu X, Yang P, Wang C, Li F, Kijlstra A. Rheumatology (Oxford); 2011 Feb 19; 50(2):293-8. PubMed ID: 21059671 [Abstract] [Full Text] [Related]